Literature DB >> 12799193

Telomere maintenance and cell cycle regulation in spontaneously immortalized T-cell lines from Nijmegen breakage syndrome patients.

Jan Konrad Siwicki1, Sofie Degerman, Krystyna H Chrzanowska, Göran Roos.   

Abstract

Nijmegen breakage syndrome (NBS) is a rare genetic instability syndrome associated with a high incidence of lymphoid malignancies. The NBS1 protein has been implicated in telomere biology suggesting that cells from NBS patients might have deficient telomere maintenance capacity. In this study we characterized spontaneously immortalized T-cell lines derived from three NBS patients regarding growth characteristics, telomere biology, expression of cell-cycle regulators, and response to DNA damage to understand the role of NBS1 in the immortalization process. In all the NBS T-cell lines the acquisition of an immortal phenotype was associated with telomere length stabilization, high telomerase activity, and increased mRNA expression of the catalytic subunit of telomerase (hTERT), together with c-myc up-regulation. Our findings provide evidence that telomere length maintenance was intact in the T lymphocytes in the absence of a full-length NBS protein, presumably due to the presence of an alternatively transcribed NBS protein of 70 kDa. Normal protein expression patterns for pRb and p53 in all the immortal lines coincided with altered expression of some cell-cycle proteins as well as with an impaired G1/S arrest after gamma irradiation, despite a seemingly normal p53/p21 pathway. The here described, spontaneously immortalized NBS derived T-cell lines can be useful in future analysis of the biologic effects in the NBS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799193     DOI: 10.1016/s0014-4827(03)00140-x

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

Review 1.  Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.

Authors:  Eugene V Barsov
Journal:  Immunotherapy       Date:  2011-03       Impact factor: 4.196

2.  Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemias.

Authors:  Sofie Degerman; Mattias Landfors; Jan Konrad Siwicki; John Revie; Magnus Borssén; Emma Evelönn; Erik Forestier; Krystyna H Chrzanowska; Patrik Rydén; W Nicol Keith; Göran Roos
Journal:  Neoplasia       Date:  2014-07-22       Impact factor: 5.715

3.  The role of nibrin in doxorubicin-induced apoptosis and cell senescence in Nijmegen Breakage Syndrome patients lymphocytes.

Authors:  Olga Alster; Anna Bielak-Zmijewska; Grazyna Mosieniak; Maria Moreno-Villanueva; Wioleta Dudka-Ruszkowska; Aleksandra Wojtala; Monika Kusio-Kobiałka; Zbigniew Korwek; Alexander Burkle; Katarzyna Piwocka; Jan K Siwicki; Ewa Sikora
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

4.  Telomere attrition and dysfunction: a potential trigger of the progeroid phenotype in nijmegen breakage syndrome.

Authors:  Raneem Habib; Ryong Kim; Heidemarie Neitzel; Ilja Demuth; Krystyna Chrzanowska; Eva Seemanova; Renaldo Faber; Martin Digweed; Reinhard Voss; Kathrin Jäger; Karl Sperling; Michael Walter
Journal:  Aging (Albany NY)       Date:  2020-06-20       Impact factor: 5.682

5.  Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia.

Authors:  Jean-Luc Perfettini; Roberta Nardacci; Mehdi Bourouba; Frédéric Subra; Laurent Gros; Claire Séror; Gwenola Manic; Filippo Rosselli; Alessandra Amendola; Peggy Masdehors; Luciana Chessa; Giuseppe Novelli; David M Ojcius; Jan Konrad Siwicki; Magdalena Chechlinska; Christian Auclair; José R Regueiro; Hugues de Thé; Marie-Lise Gougeon; Mauro Piacentini; Guido Kroemer
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

6.  Nijmegen breakage syndrome fibroblasts expressing the C-terminal truncated NBN(p70) protein undergo p38/MK2-dependent premature senescence.

Authors:  Terence Davis; Hannah S E Tivey; Amy J C Brook; David Kipling
Journal:  Biogerontology       Date:  2014-09-12       Impact factor: 4.277

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.